Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Experimental and Bioinformatic Insights into the Effects of Epileptogenic Variants on the Function and Trafficking of the GABA Transporter GAT-1

  • Piniella, Dolores
  • Canseco, Ania
  • Vidal, Silvia
  • Xiol, Clara
  • Díaz de Bustamante, Aránzazu
  • Martí-Carrera, Itxaso
  • Armstrong, Judith
  • Bastolla, Ugo
  • Zafra, Francisco
In this article, we identified a novel epileptogenic variant (G307R) of the gene SLC6A1, which encodes the GABA transporter GAT-1. Our main goal was to investigate the pathogenic mechanisms of this variant, located near the neurotransmitter permeation pathway, and compare it with other variants located either in the permeation pathway or close to the lipid bilayer. The mutants G307R and A334P, close to the gates of the transporter, could be glycosylated with variable efficiency and reached the membrane, albeit inactive. Mutants located in the center of the permeation pathway (G297R) or close to the lipid bilayer (A128V, G550R) were retained in the endoplasmic reticulum. Applying an Elastic Network Model, to these and to other previously characterized variants, we found that G307R and A334P significantly perturb the structure and dynamics of the intracellular gate, which can explain their reduced activity, while for A228V and G362R, the reduced translocation to the membrane quantitatively accounts for the reduced activity. The addition of a chemical chaperone (4-phenylbutyric acid, PBA), which improves protein folding, increased the activity of GAT-1WT, as well as most of the assayed variants, including G307R, suggesting that PBA might also assist the conformational changes occurring during the alternative access transport cycle., The work was supported by grants from the Spanish Ministry Science and Innovation (RTI2018-098712-B-I00 to FZ; PID2019-109041GB-C22/10.13039/501100011033 to UB; Ministry of Health, Carlos III/FEDER, PI20/00389 to JA; Ministry of Universities (FPU doctoral fellowship (FPU18/02152) to CX) and by the Recovery, Transformation and Resilience Plan of Madrid Autonomous University, CA1/RSUE/2021-00753 to DP., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Analysis of the circRNA and T-UCR populations identifies convergent pathways in mouse and human models of Rett syndrome

  • Siqueira, E|||0000-0002-8838-2570
  • Obiols-Guardia, Aida|||0000-0002-2548-8597
  • Jorge-Torres, Olga Caridad|||0000-0002-1219-8865
  • Oliveira-Mateos, Cristina|||0000-0003-2574-7816
  • Soler, M.
  • Ramesh-Kumar, Deepthi|||0000-0002-8987-2213
  • Setién, F.
  • van Rossum, D.
  • Pascual-Alonso, A.
  • Xiol, C.
  • Ivan, C.
  • Shimizu, M.
  • Armstrong, Judith|||0000-0003-0588-9307
  • Calin, George A
  • Pasterkamp, R. Jeroen|||0000-0003-1631-6440
  • Esteller, M.|||0000-0003-4490-6093
  • Guil, Sonia|||0000-0002-2257-3331
Noncoding RNAs play regulatory roles in physiopathology, but their involvement in neurodevelopmental diseases is poorly understood. Rett syndrome is a severe, progressive neurodevelopmental disorder linked to loss-of-function mutations of the MeCP2 gene for which no cure is yet available. Analysis of the noncoding RNA profile corresponding to the brain-abundant circular RNA (circRNA) and transcribed-ultraconserved region (T-UCR) populations in a mouse model of the disease reveals widespread dysregulation and enrichment in glutamatergic excitatory signaling and microtubule cytoskeleton pathways of the corresponding host genes. Proteomic analysis of hippocampal samples from affected individuals confirms abnormal levels of several cytoskeleton-related proteins together with key alterations in neurotransmission. Importantly, the glutamate receptor GRIA3 gene displays altered biogenesis in affected individuals and in vitro human cells and is influenced by expression of two ultraconserved RNAs. We also describe post-transcriptional regulation of SIRT2 by circRNAs, which modulates acetylation and total protein levels of GluR-1. As a consequence, both regulatory mechanisms converge on the biogenesis of AMPA receptors, with an effect on neuronal differentiation. In both cases, the noncoding RNAs antagonize MeCP2-directed regulation. Our findings indicate that noncoding transcripts may contribute to key alterations in Rett syndrome and are not only useful tools for revealing dysregulated processes but also molecules of biomarker value.